$STE · STERIS plc SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for STERIS plc ($STE) from November 5, 2026 through November 5, 2026, including 0 Form 10-K annual reports, 0 Form 10-Q quarterly earnings reports, 2 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$STE 8-K — STERIS plc
STERIS is lining up $2.1B in debt capacity to fund its Xodus Medical acquisition, signaling continued M&A expansion.
$STE 8-K — STERIS plc
STERIS beat on adjusted EPS and raised full-year guidance, with Life Sciences momentum and tariff refunds adding upside.